Theraclion SA (ALTHE.PA)
EUR 0.36
(-2.72%)
EUR 0.36
(-2.72%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.86 Million EUR | -27837.48% |
| 2022 | 21.14 Thousand EUR | 121.36% |
| 2021 | -99 Thousand EUR | -105.69% |
| 2020 | 1.73 Million EUR | 278.26% |
| 2019 | -975.55 Thousand EUR | -118.59% |
| 2018 | 5.24 Million EUR | 307.48% |
| 2017 | 1.28 Million EUR | -59.86% |
| 2016 | 3.2 Million EUR | 4.1% |
| 2015 | 3.08 Million EUR | 153.7% |
| 2014 | 1.21 Million EUR | -76.63% |
| 2013 | 5.2 Million EUR | 535.39% |
| 2012 | 818.44 Thousand EUR | -46.26% |
| 2011 | 1.52 Million EUR | 686.09% |
| 2010 | 193.73 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.27 Million EUR | 0.0% |
| 2023 Q4 | -5.86 Million EUR | 0.0% |
| 2023 Q2 | -6.86 Million EUR | 0.0% |
| 2023 FY | -5.86 Million EUR | -27837.48% |
| 2022 Q2 | -1.89 Million EUR | 0.0% |
| 2022 FY | 21.14 Thousand EUR | 121.36% |
| 2022 Q4 | 21.14 Thousand EUR | 0.0% |
| 2021 FY | -99 Thousand EUR | -105.69% |
| 2021 Q4 | -99 Thousand EUR | 0.0% |
| 2021 Q2 | -2.07 Million EUR | 0.0% |
| 2020 FY | 1.73 Million EUR | 278.26% |
| 2020 Q4 | 1.73 Million EUR | 0.0% |
| 2020 Q2 | -211.49 Thousand EUR | 0.0% |
| 2019 Q4 | -975.55 Thousand EUR | 0.0% |
| 2019 Q2 | -2.67 Million EUR | 0.0% |
| 2019 FY | -975.55 Thousand EUR | -118.59% |
| 2018 Q2 | 4.6 Million EUR | 0.0% |
| 2018 Q4 | 5.24 Million EUR | 0.0% |
| 2018 FY | 5.24 Million EUR | 307.48% |
| 2017 Q2 | -2.04 Million EUR | 0.0% |
| 2017 FY | 1.28 Million EUR | -59.86% |
| 2017 Q4 | 1.28 Million EUR | 0.0% |
| 2016 Q4 | 3.2 Million EUR | 0.0% |
| 2016 Q2 | 4.16 Million EUR | 0.0% |
| 2016 FY | 3.2 Million EUR | 4.1% |
| 2015 FY | 3.08 Million EUR | 153.7% |
| 2015 Q4 | 3.08 Million EUR | 0.0% |
| 2015 Q2 | -562.4 Thousand EUR | 0.0% |
| 2014 FY | 1.21 Million EUR | -76.63% |
| 2014 Q2 | -1.97 Million EUR | 0.0% |
| 2014 Q4 | 1.21 Million EUR | 0.0% |
| 2013 FY | 5.2 Million EUR | 535.39% |
| 2013 Q4 | 5.2 Million EUR | 0.0% |
| 2012 FY | 818.44 Thousand EUR | -46.26% |
| 2011 FY | 1.52 Million EUR | 686.09% |
| 2010 FY | 193.73 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | 137.894% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | -573.444% |
| Carmat SA | 49.63 Million EUR | 111.815% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | 150.872% |
| Euromedis Groupe | -8.82 Million EUR | 33.555% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 111.424% |
| Ikonisys S.A. | 3.19 Million EUR | 283.376% |
| Implanet S.A. | 5.9 Million EUR | 199.348% |
| Median Technologies SA | 3.5 Million EUR | 267.271% |
| SpineGuard SA | 215.79 Thousand EUR | 2817.617% |
| Euroapi S.A. | 191 Million EUR | 103.07% |
| Guerbet SA | 332.59 Million EUR | 101.763% |
| Ion Beam Applications SA | -67.72 Million EUR | 91.34% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 100.101% |
| Sequana Medical NV | 14.2 Million EUR | 141.291% |